Skip to main content
. 2020 May 3;52(6):971–977.e3. doi: 10.1016/j.immuni.2020.04.023

Table 1.

Clinical and Pathological Characteristics of the COVID-19 Patients

Pt# Sex Age Travel in Wuhan Fever Fatigue LymphocyteCount Days in hospital BT CT Scan BT NA Test Discharge CT Scan Discharge NA Test
1 F 51 yes yes yes 1.1 × 109/L 33 patchy ground glass shadows on both lungs P improvement N
2 F 42 no no no 2.5 × 109/L 27 multiple patchy ground glass and high-density shadows in both lungs P improvement N
3 M 32 no yes no 1.7 × 109/L 36 exudative lesion of the right lower lung P improvement N
4 M 49 no yes no 1.5 × 109/L 32 patchy ground glass shadows on both lungs P significant improvement N
5 F 62 no yes yes 0.8 × 109/L 37 patchy ground glass shadows on both lungs P significant improvement N
6 M 32 no yes yes 2.1 × 109/L 17 multiple ground glass shadows in both lungs P significant improvement N
7 M 32 no yes yes 1.7 × 109/L 34 multiple ground glass lesions in the lower lobe of the right lung P significant improvement N
8 F 57 yes yes yes 1.3 × 109/L 45 multiple flaky ground glass shadows in the subpleural areas of both lungs, some accompanied by consolidation P significant improvement N
9 F 26 no yes no 2.9 × 109/L 12 right lung inflammation P normal N
10 M 68 no yes no 0.7 × 109/L 14 multiple patchy ground glass shadows are seen in the left lung, and the upper lobe of the left lung is obvious P significant improvement N
11 F 37 no no yes 1.9 × 109/L 12 double lung veins thickened P normal N
12 F 29 no yes yes 1.9 × 109/L 13 ground glass in the pleura of the lower lobe of both lungs P normal N
13 F 31 yes yes no 1.1 × 109/L 19 patchy ground glass shadows on both lungs P significant improvement N
14 M 35 no yes yes 2.3 × 109/L 11 multiple ground glass shadows in both lungs P normal N

Pt, patient; F, female; M, male; P, positive; N, negative; BT, before treatment; NA, nucleic acid.